First Physicians Capital Group, Inc. (“FPCG” or the “Company”)
(OTCBB: FPCG), an operator of healthcare services firms, announced
preliminary un-audited results for the Company’s fiscal year ended
September 30, 2010 (“Fiscal 2010”).
The Company completed a strategic review of its operations at
the end of the recent fiscal year. The Company determined that the
best course was to reorganize its operations. This decision was
based upon a combination of factors including, but not limited to,
input from potential merger partners, potential equity and debt
funding sources, operating performance significantly below
expectations for certain of its facilities, and as a response to
local market economic conditions including the expected impact of
changes in healthcare law.
In pursuit of this reorganization, FPCG has undertaken the
following strategic initiatives beginning in Fiscal 2011:
- Sold underperforming facilities in its
portfolio of assets in Oklahoma
- Held certain operations as discontinued
or held for sale as they are not expected to meet operating
performance expectations or internal hurdle rates in Fiscal
2011
- Reduced and outsourced certain back
office and administrative functions to better align cost structures
and business volume
- Reorganized operations and real estate
holdings into separate entities to better match current and future
working capital sources and needs
The Company will provide further updates on the progress of its
reorganization and transition plan, and on any related transactions
and financings with its first fiscal quarter 10-Q filing in
February or earlier regulatory filings as necessary.
The Company continues to work with its auditors to complete its
Form 10-K filing for Fiscal 2010 and it expects to file prior to or
on February 10, 2011. The Company also expects to file its Form
10-Q for the first fiscal quarter ended December 31, 2010 in a
timely manner on or about February 15, 2011. As mentioned above,
the Company has been working on a number of material transactions
subsequent to the close of its Fiscal 2010 year. Given the
potential financial impact on reported results, FPCG and its
auditors are taking the time to complete the audit and financial
statements with these latest transactions in mind. The Company’s
stock symbol, FPCG.OB, may carry an “E” after the ticker symbol for
a period of time until its Form 10-K is filed. The Company believes
it will continue to trade on the OTC BB exchange during this
period.
Table 1. First Physicians Capital Group, Inc. Preliminary
Consolidated Income Statement (in thousands)
Fiscal Year Ended
Sep. 30, 2009
Fiscal Year Ended Sep. 30, 2010 Fiscal Year Ended Sep.
30, 2010 FPCG FPCG Assets Sold/ FPCG
Consol Discont. Pro Forma FPCG Consol
Consol Consol Held for Sale Pro Forma
Ops Adj(1) Pro Forma Revenue from
services $ 39,090 $ 39,502 $
5,170 $ 34,332 $ 10,852 $
- $ 23,481
Cost and expenses:
Selling, general and administrative
expenses
39,514 38,161 7,274 30,886 11,426 - 19,460
Provision for doubtful accounts
4,561 5,914 863 5,051 262 - 4,789
Amortization of stock-based
compensation
1,245 1,078 - 1,078 - - 1,078
Impairment of long-lived assets and
goodwill
209 - - - - - -
Depreciation and amortization
1,102 1,470 124
1,346 387 - 959
Total costs and expenses
46,631 46,623
8,262 38,362
12,075 - 26,286
Operating income
(7,541 ) (7,121 ) (3,092
) (4,029 ) (1,224 ) -
(2,805 )
Interest income
42 496 4 492 42 109 559
Interest expense
(2,094 ) (2,012 ) (824 ) (1,188 ) (584 ) - (604 )
Other income (expense)
(281 ) - - - 104 - (104 )
Minority interest
(177 ) (681 ) - (681 ) -
- (681 )
Net loss from operations before
taxation and non-cash beneficial conversion feature
(10,051 ) (9,319 ) (3,913
) (5,407 ) (1,662 ) 109
(3,636 )
Taxation
- - - - - - -
Non-cash beneficial conversion feature
preferred dividend
(317 ) (48 ) - (48 ) - - (48 )
Net loss allocable to
common stockholders
$ (10,368 ) $ (9,367 )
$ (3,913 ) $ (5,454 )
$ (1,662 ) $ 109 $
(3,684 )
EBITDA
$ (4,985 ) $ (4,573 )
$ (2,968 ) $ (1,605 )
$ (836 ) $ - $
(769 )
FPCG Corporate Overhead
(3,607 ) (2,660 ) - (2,660 ) - - (2,660 )
EBITDA less
FPCG Corporate Overhead
$ (1,378 ) $ (1,912 )
$ (2,968 ) $ 1,055 $
(836 ) $ - $ 1,892
Notes:
(1) Pro forma adjustment made for approximately $109,000 of
annual interest income earned on seller note received as
consideration for sale of discontinued assets.
Important Notice
It should be noted that EBITDA is a financial measure that is
not recognized under accounting principles generally accepted in
the United States of America (GAAP). EBITDA should not be
considered as an alternative to, or more meaningful than, net
income, operating income, cash flows from operations or other
traditional indications of a company’s operating performance or
liquidity that are derived in accordance with GAAP. In addition,
the Company’s calculations of EBITDA may not be comparable to
similarly titled measures being disclosed by other companies,
limiting their usefulness as comparative measures. The Company
discloses EBITDA as it is a commonly referred to financial metric
used in the investing community to evaluate the performance of
companies in our industry. The Company believes that disclosure of
EBITDA is helpful to those reviewing its performance, as EBITDA
provides information on the Company’s ability to meet debt service,
capital expenditure and working capital requirements and management
believes that EBITDA is also a useful indicator of the Company’s
operating performance.
To better facilitate comparisons from reporting period to
reporting period on the productivity of our healthcare facilities
operations, non-GAAP supplemental information is provided. The
Company highlights:
- Revenue from Services
- Provisions for Doubtful Accounts (Bad
Debt Expense)
- EBITDA less FPCG Corporate
Overhead
- FPCG Corporate Overhead, our overhead
expense at the corporate holding company
About First Physicians Capital Group, Inc.
First Physicians Capital Group, Inc. is an operator of
healthcare services firms in the U.S. For more information, please
visit www.fpcapitalgroup.com.
Safe-Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This press release may contain forward-looking
information within the meaning of Section 21E of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), including
all statements that are not statements of historical fact regarding
the intent, belief or current expectations of the Company, its
directors or its officers with respect to, among other things: (i)
the Company’s financing plans; (ii) trends affecting the Company’s
financial condition or results of operations; (iii) the Company’s
growth strategy and operating strategy; and (iv) the declaration
and payment of dividends. The words “may,” “would,” “will,”
“expect,” “estimate,” “anticipate,” “believe,” “intend” and similar
expressions and variations thereof are intended to identify
forward-looking statements. Investors are cautioned that any such
forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, many of which are beyond the
Company’s ability to control, and that actual results may differ
materially from those projected in the forward-looking statements
as a result of various factors including the risks disclosed in the
Company’s Forms 10-K and 10-Q filed with the Securities Exchange
Commission.
First Physicians Capital (CE) (USOTC:FPCG)
過去 株価チャート
から 11 2024 まで 12 2024
First Physicians Capital (CE) (USOTC:FPCG)
過去 株価チャート
から 12 2023 まで 12 2024